Skip to main content


Mantle Cell Lymphoma

Featured

Quiz
True or False: Older patients with MCL have a high rate of comorbidities impacting treatment choices and OS.
Quiz
True or False: KTE-X19 is a cost-effective alternative to the current standard of care for relapsed/refractory MCL.
News
KTE-X19 is a potentially cost-effective alternative to the current standard of care for relapsed/refractory MCL.
Quiz
True or False: Positive MRD status after induction and consolidation treatments for patients with MCL is associated…
Quiz
True or False: MRD status prior to autologous stem cell transplantation is an early predictor of PFS and OS in younger…
Back to Top